ImmunityBio, Inc.
DE ˙ DB ˙ US45256X1037
6,13 € ↓ -0,20 (-3,16%)
2026-06-05
DEL PRIS
SecurityDE:26CA / ImmunityBio, Inc.
InstitutionLegal & General Group Plc
Latest Disclosed Ownership253,692 shares
Latest Disclosed Value $ 1,945,818
Legal & General Group Plc reports 13.26% decrease in ownership of 26CA / ImmunityBio, Inc.

On May 8, 2026 - Legal & General Group Plc filed a 13F-HR form disclosing ownership of 253,692 shares of ImmunityBio, Inc. (DE:26CA) valued at $1,664,220 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 292,468 shares of ImmunityBio, Inc.. This represents a change in shares of -13.26% during the quarter. The current value of the position is $1,555,132 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F IMMUNITYBIO COM 45256X103 253,692 -38,776 -13.26 1,946 235.92 0.0002
2026-02-09 2025-12-31 13F IMMUNITYBIO COM 45256X103 292,468 69,580 31.22 579 5.66 0.0001
2025-11-13 2025-09-30 13F IMMUNITYBIO COM 45256X103 222,888 17,410 8.47 548 1.11 0.0001
2025-08-12 2025-06-30 13F IMMUNITYBIO COM 45256X103 205,478 21,715 11.82 542 -1.99 0.0001
2025-05-15 2025-03-31 13F IMMUNITYBIO COM 45256X103 183,763 52,399 39.89 553 64.58 0.0002
2025-02-13 2024-12-31 13F IMMUNITYBIO COM 45256X103 131,364 0 0.00 336 -31.15 0.0001
2025-02-28 2024-09-30 13F/A-2 IMMUNITYBIO COM 45256X103 131,364 464 0.35 488 -40.99 0.0001
2024-11-14 2024-09-30 13F/A-1 IMMUNITYBIO COM 45256X103 142,525 464 530 0.0001
2024-11-14 2024-09-30 13F IMMUNITYBIO COM 45256X103 142,525 464 530 0.0001
2025-05-29 2024-06-30 13F/A-1 IMMUNITYBIO COM 45256X103 130,900 15,754 13.68 827 33.82 0.0002
2024-08-14 2024-06-30 13F IMMUNITYBIO COM 45256X103 142,061 26,915 898 0.0002
2025-05-29 2024-03-31 13F/A-2 IMMUNITYBIO COM 45256X103 115,146 -5,383 -4.47 618 2.15 0.0002
2024-07-01 2024-03-31 13F/A-1 IMMUNITYBIO COM 45256X103 115,146 -5,383 618 0.0001
2024-05-14 2024-03-31 13F IMMUNITYBIO COM 45256X103 115,146 -5,383 618 0.0001
2025-05-29 2023-12-31 13F/A-1 IMMUNITYBIO COM 45256X103 120,529 2,566 2.18 605 204.02 0.0002
2024-02-15 2023-12-31 13F IMMUNITYBIO COM 45256X103 120,529 2,566 605 0.0002
2023-11-14 2023-09-30 13F IMMUNITYBIO COM 45256X103 117,963 -1,403 -1.18 199 -39.88 0.0001
2023-08-14 2023-06-30 13F IMMUNITYBIO COM 45256X103 119,366 63,839 114.97 332 227.72 0.0001
2023-05-15 2023-03-31 13F IMMUNITYBIO COM 45256X103 55,527 10,679 23.81 101 -55.51 0.0000
2023-02-14 2022-12-31 13F IMMUNITYBIO COM 45256X103 44,848 -1,125 -2.45 227 -0.87 0.0001
2022-11-14 2022-09-30 13F IMMUNITYBIO COM 45256X103 45,973 3,936 9.36 229 45.86 0.0001
2022-08-22 2022-06-30 13F IMMUNITYBIO COM 45256X103 42,037 9,898 30.80 157 -12.78 0.0001
2022-05-16 2022-03-31 13F IMMUNITYBIO COM 45256X103 32,139 1,163 3.75 180 -4.26 0.0001
2022-02-14 2021-12-31 13F IMMUNITYBIO COM 45256X103 30,976 0 0.00 188 -37.54 0.0001
2021-11-15 2021-09-30 13F IMMUNITYBIO COM 45256X103 30,976 18,555 149.38 301 69.10 0.0001
2021-08-12 2021-06-30 13F IMMUNITYBIO COM 45256X103 12,421 2,998 31.82 178 -20.54 0.0001
2021-05-17 2021-03-31 13F IMMUNITYBIO COM 45256X103 9,423 -8,167 -46.43 224 -4.27 0.0001
2021-02-12 2020-12-31 13F NANTKWEST COM 63016Q102 17,590 13,832 368.07 234 800.00 0.0001
2020-11-13 2020-09-30 13F NANTKWEST COM 63016Q102 3,758 -829 -18.07 26 -53.57 0.0000
2020-08-14 2020-06-30 13F NANTKWEST COM 63016Q102 4,587 98 2.18 56 1,020.00 0.0000
2019-08-14 2019-06-30 13F NANTKWEST COM 63016Q102 4,489 0 0.00 5 -28.57 0.0000
2019-05-15 2019-03-31 13F NANTKWEST COM 63016Q102 4,489 0 0.00 7 40.00 0.0000
2019-02-15 2018-12-31 13F NANTKWEST COM 63016Q102 4,489 0 0.00 5 -70.59 0.0000
2018-11-20 2018-09-30 13F NANTKWEST COM 63016Q102 4,489 0 0.00 17 21.43 0.0000
2018-08-10 2018-06-30 13F NANTKWEST COM 63016Q102 4,489 0 0.00 14 -17.65 0.0000
2018-05-17 2018-03-31 13F NANTKWEST COM 63016Q102 4,489 -447 -9.06 17 -22.73 0.0000
2018-02-13 2017-12-31 13F NANTKWEST COM 63016Q102 4,936 0 0.00 22 -18.52 0.0000
2017-11-09 2017-09-30 13F NANTKWEST COM 63016Q102 4,936 0 0.00 27 -27.03 0.0000
2017-08-03 2017-06-30 13F NANTKWEST COM 63016Q102 4,936 2,313 88.18 37 311.11 0.0000
2017-05-12 2017-03-31 13F NANTKWEST COM 63016Q102 2,623 -601 -18.64 9 -50.00 0.0000
2017-02-13 2016-12-31 13F NANTKWEST COM 63016Q102 3,224 3,224 18 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.